Cyntegrity | Data Science for Clinical Trials
Follow Us on LinkedIn

Leadership Roundtable

4 September 2025 @ Microsoft Messeturm Franktfurt, Germany. "Implementing QbD with AI" - a complimentary forum for 40 senior delegates. Request an invitation while seats last.

Thank you—your registration is now on record. You will receive a personal confirmation email within 24 hours.

Accelerate Trials, Stay Inspection-Ready

Boards, regulators, and patients all expect faster studies that never compromise on quality. On 4 September, join Microsoft and Cyntegrity for a high-impact roundtable on how AI-powered Quality-by-Design (QbD) and Risk-Based Quality Management (RBQM) deliver inspection-ready trials without blowing the budget.

Key Take-aways

Trust

Metric framework for Responsible AI in GxP.

Security

Data protection playbook to satisfy GDPR & ICH E6(R3).

ROI

Proven time-to-value from predictive risk signals.

AI Futurescape

Speaker Sneak Peek

First speakers announced; a growing line-up of leaders driving inspection-ready AI.

"Leaders who build inspection-ready trials don't gamble on quality - they engineer it."

Artem Andrianov, PhD · CEO – Cyntegrity • AI-Augmented RBQM

Artem Andrianov, PhD

CEO & Founder
Cyntegrity
Aurelie Dequelson, Head of Risk Surveillance at Novartis

Aurelie Dequelson

Head of Risk Surveillance
Novartis
Robert King – Executive Director, Business Segment Lead: FSP Regional Hub Leadership at Thermo Fisher Scientific

Robert King

Business Segment Lead, FSP Hubs
Thermo Fisher Scientific
Ida Holme, MD - Head of RBQM at Novo Nordisk

Ida Holme, MD

Head of RBQM
Novo Nordisk
Dr Beat Widler, Managing Partner at Widler & Schiemann AG

Beat Widler, PhD

Managing Partner
Widler & Schiemann AG
Dr Anke Diehl, Chief Transformation Officer, University Medicine Essen

Dr Anke Diehl

Chief Transformation Officer
University Medicine Essen
Johann Proeve, PhD at Cyntegrity

Johann Proeve, PhD

Chief Scientific Officer
Cyntegrity
Shehnaz Vakharia, MRQA - VP, APAC at ADAMAS

Shehnaz Vakharia, MRQA

VP, APAC
ADAMAS Consulting
Patrick Lamplé - Healthcare and Life Sciences Industry Advisor at Microsoft

Patrick Lample

HC & LS Industry Advisor
Microsoft
Preliminary Agenda

Preliminary Agenda Snapshot

12:00 | Arrival & Networking Lunch

12:30 | Opening - "Why AI-Driven QbD Has Reached the Boardroom"
12:40 | Keynote 1 - "Responsible AI in Practice: Trust, Security, & ROI for Clinical Trials"
13:10 | Dual Keynote - "From Insight to Action: AI-Driven Critical-to-Quality and Dynamic Risk Libraries"

13:35 | Espresso & Peer Exchange

13:50 | Keynote 3 - "Integrated Quality and Risk Management Approach (IQRMA) in Practice"
14:10 | Case Study - "From Manual Checks to Predictive Quality: How a Sponsor Cut Database Lock Time by 30%"
14:35 | Keynote 4 - "Operational Intelligence: Seeding AI Today to Streamline Tomorrow's Trial Execution"

15:00 | Short Break

15:05 | Executive Panel - "Trust, Validation & Reproducibility: De-Risking AI-Adoption"

15:45 | Interactive Q&A & Next Steps
16:00 | Closing Reception & Skyline Networking (until 17:00)
Event Details

Event Details


Secure your complimentary seat - only 40 senior places available. RSVP by 2 September, and please cancel promptly if your plans change.

For any questions or additional details please reach out to Tamara Beck, our MyRBQM Academy Operations Manager, at:

Event Dates

Date

Thursday, September 4, 2025

Event Time

Time

12:00 - 17:00 CEST

Event Format

Format

In-person: Frankfurt, Germany

Event Format

Cost

Complimentary (incl. lunch, cocktail)

Who Should Attend

VPs / Directors in Clinical Ops, Quality, Digital Transformation & Data Science who plan to embed Responsible AI in study oversight within 12 months.

AI-Augmented RBQM Solutions

© 2025 Cyntegrity - All Rights Reserved

Cyntegrity | Data Science for Clinical Trials